Abstract 5098: A mouse DLL4 cross-reactive variant of MEDI0639 disrupts functional vessel formation and inhibits tumor growth in preclinical models

MLA

Melissa Damschroder, et al. “Abstract 5098: A Mouse DLL4 Cross-Reactive Variant of MEDI0639 Disrupts Functional Vessel Formation and Inhibits Tumor Growth in Preclinical Models.” Cancer Research, vol. 73, Apr. 2013, p. 5098. EBSCOhost, https://doi.org/10.1158/1538-7445.am2013-5098.

APA

Melissa Damschroder, Adeela Kamal, Nicholas Holoweckyj, Patrick Strout, Ching Ching Leow, Shannon Breen, Kimberly E. Cook, Philip Brohawn, David W. Jenkins, Gennady Gololobov, Jiaqi Huang, Ping Tsui, Ivan Inigo, Jon Chesebrough, Martin Korade, Haihong Zhong, Juliana Maynard, Meggan Czapiga, Sally-Ann Ricketts, & Song H. Cho. (2013). Abstract 5098: A mouse DLL4 cross-reactive variant of MEDI0639 disrupts functional vessel formation and inhibits tumor growth in preclinical models. Cancer Research, 73, 5098. https://doi.org/10.1158/1538-7445.am2013-5098

Chicago

Melissa Damschroder, Adeela Kamal, Nicholas Holoweckyj, Patrick Strout, Ching Ching Leow, Shannon Breen, Kimberly E. Cook, et al. 2013. “Abstract 5098: A Mouse DLL4 Cross-Reactive Variant of MEDI0639 Disrupts Functional Vessel Formation and Inhibits Tumor Growth in Preclinical Models.” Cancer Research 73 (April): 5098. doi:10.1158/1538-7445.am2013-5098.